Emerging roles of post-translational modifications in signal transduction and angiogenesis

Proteomics

Volumn 15, Issue 2-3, 2015, Pages 300-309

  Rahimi, Nader ^a   Costello, Catherine E ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylation; Cell biology; Glycosylation; Phosphorylation; Tandem mass spectrometry; VEGF receptor

Indexed keywords

ARGININE; IMMUNOGLOBULIN; LYSINE; PROTEIN KINASE; SERINE; THREONINE; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; GLYCOSYLATION; HUMAN; LIGAND BINDING; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ACETYLATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION; ACETYLATION; AMINO ACID SEQUENCE; ANIMAL; CHEMICAL STRUCTURE; METABOLISM; MOLECULAR GENETICS; NEOVASCULARIZATION (PATHOLOGY); PHOSPHORYLATION;

ACETYLATION; AMINO ACID SEQUENCE; ANIMALS; GLYCOSYLATION; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84921352104     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201400183     Document Type: Review

References (63)

1. Folkman, J., Angiogenesis. Ann. Rev. Med. 2006, 57, 1-18.
2. Carmeliet, P., Angiogenesis in life, disease and medicine. Nature 2005, 438, 932-936.
3. Loges, S., Mazzone, M., Hohensinner, P., Carmeliet, P., Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited. Cancer Cell 2009, 15, 167-170.
4. Paez-Ribes, M., Allen, E., Hudock, J., Takeda, T. et al., Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009, 15, 220-231.
5. Welti, J., Loges, S., Dimmeler, S., Carmeliet, P., Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. J. Clin. Invest. 2013, 123, 3190-3200.
6. Ebos, J. M., Lee, C. R., Cruz-Munoz, W., Bjarnason, G. A. et al., Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell. 2009, 15, 232-239.
7. Chung, A. S., Kowanetz, M., Wu, X., Zhuang, G. et al., Differential drug class-specific metastatic effects following treatment with a panel of angiogenesis inhibitors. J. Pathol. 2012, 227, 404-416.
8. Singh, M., Ferrara, N., Modeling and predicting clinical efficacy for drugs targeting the tumor milieu. Nat. Biotechnol. 2012, 30, 648-657.
9. Lemmon, M. A., Schlessinger, J., Cell signaling by receptor tyrosine kinases. Cell 2010, 141, 1117-1134.
10. Williams, D. B., Beyond lectins: the calnexin/calreticulin chaperone system of the endoplasmic reticulum. J. Cell Sci. 2006, 119, 615-623.
11. Tao, Q., Backer, M. V., Backer, J. M., Terman, B. I., Kinase insert domain receptor (KDR) extracellular immunoglobulin-like domains 4-7 contain structural features that block receptor dimerization and vascular endothelial growth factor-induced signaling. J. Biol. Chem. 2001, 276, 21916-21923.
12. Nacev, B. A., Grassi, P., Dell, A., Haslam, S. M. et al., The antifungal drug itraconazole inhibits vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, trafficking, and signaling in endothelial cells. J. Biol. Chem. 2011, 286, 44045-44056.
13. Takahashi, T, Shibuya, M, The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts. Oncogene 1997, 14, 2079-2089.
14. Srinivasan, S, Meyer, R. D., Lugo, R., Rahimi, N., Identification of PDCL3 as a novel chaperone protein involved in the generation of functional VEGF receptor 2. J. Biol. Chem. 2013, 288, 23171-23181.
15. Dougher, M, Terman, B. I., Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization. Oncogene 1999, 18, 1619-1627.
16. Meyer, R. D., Sacks, D. B., Rahimi, N., IQGAP1-dependent signaling pathway regulates endothelial cell proliferation and angiogenesis. PloS One 2008, 3, e3848.
17. Matsumoto, T., Bohman, S., Dixelius, J., Berge, T. et al., VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis. EMBO J. 2005, 24, 2342-2353.
18. Singh, A. J., Meyer, R. D., Band, H., Rahimi, N., The carboxyl terminus of VEGFR-2 is required for PKC-mediated down-regulation. Mol. Biol. Cell. 2005, 16, 2106-2118.
19. Meyer, R. D., Singh, A. J., Rahimi, N., The carboxyl terminus controls ligand-dependent activation of VEGFR-2 and its signaling. J. Bio. Chem. 2004, 279, 735-742.
20. Singh, A. J., Meyer, R. D., Navruzbekov, G., Shelke, R. et al., A critical role for the E3-ligase activity of c-Cbl in VEGFR-2-mediated PLCgamma1 activation and angiogenesis. Proc. Natl. Acad. Sci. USA 2007, 104, 5413-5418.
21. Sun, Z., Li, X., Massena, S., Kutschera, S. et al., VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd. J. Exp. Med. 2012, 209, 1363-1377.
22. Subramani, J., Ghosh, M., Rahman, M. M., Caromile, L. A. et al., Tyrosine phosphorylation of CD13 regulates inflammatory cell-cell adhesion and monocyte trafficking. J. Immunol. 2013, 191, 3905-3912.
23. Sakurai, Y., Ohgimoto, K., Kataoka, Y., Yoshida, N. et al., Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. Proc. Natl. Acad. Sci. USA 2005, 102, 1076-1081.
24. Dayanir, V., Meyer, R. D., Lashkari, K., Rahimi, N., Identification of tyrosine residues in vascular endothelial growth factor receptor-2/FLK-1 involved in activation of phosphatidylinositol 3-kinase and cell proliferation. J. Biol. Chem. 2001, 276, 17686-17692.
25. Holmqvist, K., Cross, M. J., Rolny, C., Hagerkvist, R. et al., The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration. J. Biol. Chem. 2004, 279, 22267-22275.
26. Meyer, R. D., Latz, C., Rahimi, N., Recruitment and activation of phospholipase Cgamma1 by vascular endothelial growth factor receptor-2 are required for tubulogenesis and differentiation of endothelial cells. J. Biol. Chem. 2003, 278, 16347-16355.
27. Olsson, A. K., Dimberg, A., Kreuger, J., Claesson-Welsh, L., VEGF receptor signalling-in control of vascular function. Nat. Rev. Mol. Cell Biol. 2006, 7, 359-371.
28. Rahimi, N., VEGFR-1 and VEGFR-2: two non-identical twins with a unique physiognomy. Front Biosci. 2006, 11, 818-829.
29. Meyer, R. D., Srinivasan, S., Singh, A. J., Mahoney, J. E. et al., PEST motif serine and tyrosine phosphorylation controls vascular endothelial growth factor receptor 2 stability and downregulation. Mol. Cell Biol. 2011, 31, 2010-2025.
30. Shaik, S., Nucera, C., Inuzuka, H., Gao, D. et al., SCF(beta-TRCP) suppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2. J. Exp. Med. 2012, 209, 1289-1307.
31. McMullen, M. E., Bryant, P. W., Glembotski, C. C., Vincent, P. A. et al., Activation of p38 has opposing effects on the proliferation and migration of endothelial cells. J. Biol. Chem. 2005, 280, 20995-21003.
32. Issbrucker, K., Marti, H. H., Hippenstiel, S., Springmann, G. et al., p38 MAP kinase-a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability. FASEB J. 2003, 17, 262-264.
33. Gratton, J. P., Morales-Ruiz, M., Kureishi, Y., Fulton, D. et al., Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J. Biol. Chem. 2001, 276, 30359-30365.
34. Bedford, M. T., Richard, S., Arginine methylation an emerging regulator of protein function. Mol. Cell. 2005, 18, 263-272.
35. Huang, J., Berger, S. L., The emerging field of dynamic lysine methylation of non-histone proteins. Curr. Opin. Genet. Dev. 2008, 18, 152-158.
36. Paik, W. K., Paik, D. C., Kim, S., Historical review: the field of protein methylation. Trends Biochem. Sci. 2007, 32, 146-152.
37. Katz, J. E., Dlakic, M, Clarke, S., Automated identification of putative methyltransferases from genomic open reading frames. Mol. Cell. Proteomics 2003, 2, 525-540.
38. Bedford, M. T., Arginine methylation at a glance. J.Cell Sci. 2007, 120, 4243-4246.
39. Martin, C., Zhang, Y., The diverse functions of histone lysine methylation. Nat. Rev. Mol. Cell. Biol. 2005, 6, 838-849.
40. Dillon, S. C., Zhang, X., Trievel, R. C., Cheng, X., The SET-domain protein superfamily: protein lysine methyltransferases. Genome Biol. 2005, 6, 227.
41. Petrossian, T. C., Clarke, S. G., Uncovering the human methyltransferasome. Mol. Cell. Proteomics 2011, 10, M110 000976.
42. Tajul-Arifin, K., Teasdale, R., Ravasi, T., Hume, D. A. et al., Identification and analysis of chromodomain-containing proteins encoded in the mouse transcriptome. Genome Res. 2003, 13, 1416-1429.
43. Bienz, M., The PHD finger, a nuclear protein-interaction domain. Trends Biochem. Sci. 2006, 31, 35-40.
44. Kouzarides, T., Chromatin modifications and their function. Cell 2007, 128, 693-705.
45. Bannister, A. J., Kouzarides, T., Regulation of chromatin by histone modifications. Cell Res. 2011, 21, 381-395.
46. Li, D., Roberts, R., WD-repeat proteins: structure characteristics, biological function, and their involvement in human diseases. Cell. Mol. Life Sci. 2001, 58, 2085-2097.
47. Bedford, M. T., Frankel, A., Yaffe, M. B., Clarke, S. et al., Arginine methylation inhibits the binding of proline-rich ligands to Src homology 3, but not WW, domains. J. Biol. Chem. 2000, 275, 16030-16036.
48. Zhu, W., Mustelin, T., David, M., Arginine methylation of STAT1 regulates its dephosphorylation by T cell protein tyrosine phosphatase. J. Biol. Chem. 2002, 277, 35787-35790.
49. Jansson, M., Durant, S. T., Cho, E. C., Sheahan, S. et al., Arginine methylation regulates the p53 response. Nat. Cell Biol. 2008, 10, 1431-1439.
50. Yamagata, K., Daitoku, H., Takahashi, Y., Namiki, K. et al., Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt. Mol. Cell. 2008, 32, 221-231.
51. Yamaguchi, H., Chang, S. S., Hsu, J. L., Hung, M. C., Signaling cross-talk in the resistance to HER family receptor targeted therapy. Oncogene 2014, 33, 1073-1081.
52. Hsu, J. M., Chen, C. T., Chou, C. K., Kuo, H. P. et al., Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation. Nat. Cell Biol. 2011, 13, 174-181.
53. Kunizaki, M., Hamamoto, R., Silva, F. P., Yamaguchi, K. et al., The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3. Cancer Res. 2007, 67, 10759-10765.
54. Meyer, R. D., Mohammadi, M., Rahimi, N., A single amino acid substitution in the activation loop defines the decoy characteristic of VEGFR-1/FLT-1. J. Biol. Chem. 2006, 281, 867-875.
55. Rahimi, N., Dayanir, V., Lashkari, K., Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells. J. Biol. Chem. 2000, 275, 16986-16992.
56. Hartsough, E. J., Meyer, R. D., Chitalia, V., Jiang, Y. et al., Lysine methylation promotes VEGFR-2 activation and angiogenesis. Sci. Signal. 2013, 6, ra104.
57. Yang, X. J., Seto, E., Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol. Cell 2008, 31, 449-461.
58. Berger, S. L., The complex language of chromatin regulation during transcription. Nature 2007, 447, 407-412.
59. Sabo, A., Lusic, M., Cereseto, A., Giacca, M., Acetylation of conserved lysines in the catalytic core of cyclin-dependent kinase 9 inhibits kinase activity and regulates transcription. J. Mol. Cell Biol. 2008, 28, 2201-2212.
60. Yang, F. C., Tan, B. C., Chen, W. H., Lin, Y. H. et al., Reversible acetylation regulates salt-inducible kinase (SIK2) and its function in autophagy. J. Biol. Chem. 2013, 288, 6227-6237.
61. Zecchin, A., Pattarini, L., Gutierrez, M. I., Mano, M. et al., Reversible acetylation regulates vascular endothelial growth factor receptor-2 activity. J. Mol. Cell Biol. 2014, 6, 116-127.
62. Lv, L., Xu, Y. P., Zhao, D., Li, F. L. et al., Mitogenic and oncogenic stimulation of K433 acetylation promotes PKM2 protein kinase activity and nuclear localization. Mol. Cell. 2013, 52, 340-352.
63. Kouzarides, T., Acetylation: a regulatory modification to rival phosphorylation? EMBO Journal. 2000, 19, 1176-1179.